# Evaluation of Extended Intravenous of Beta-lactams in the Treatment of Serious Gram-negative Infections in Critically Ill Patients

> **NCT01600768** · NA · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Gram-Negative Bacterial Infections

## Interventions

- **DRUG:** Beta-Lactams
- **DRUG:** Beta-Lactams

## Key facts

- **NCT ID:** NCT01600768
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01600768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01600768, "Evaluation of Extended Intravenous of Beta-lactams in the Treatment of Serious Gram-negative Infections in Critically Ill Patients". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01600768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*